SAB Biotherapeutics SABS Institutional Ownership

NASDAQ SABS

$3.72 +0.00 (+0.00%)

At close: Sep 4, 2026 · 4:00 PM EDT

Institutions by Trading Activity

88 Institutions

Increased 58 65.9%

Unchanged 14 15.9%

Reduced 16 18.2%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

85.89%

▼-43.29 pp QoQ

Shares Held by Institutions

68.50Mn

of 79.75Mn outstanding

▲+5.93% QoQ

Shares Outstanding

79.75Mn

11.25Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+12 vs prior quarter

Net Shares Added (QoQ)

+3.84Mn

accumulated since last quarter

Value of Holdings

$254.83Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

SAB Biotherapeutics, Inc. (NASDAQ:SABS) appears in 88 institutional 13F filings for the quarter ending June 2026.

Collectively, these holders controlled 85.9% of SAB Biotherapeutics's outstanding shares in June 2026, down from 129.2% in March 2026.
Their total shares held in SABS increased 5.93% quarter over quarter, and separately, investors owning SAB Biotherapeutics increased 266.67% from a year ago.
Of these 88 holders, 58 added to their stakes in SAB Biotherapeutics, 16 trimmed positions, and 14 made no changes.
Institutional investors collectively held 68.5Mn shares in SAB Biotherapeutics as of June 2026, up by 3.84Mn shares quarter on quarter, and up 66.59Mn shares year over year.
Caligan Partners LP leads ownership in SABS with 7.97Mn shares as of June 30, 2026, equal to 9.99% of outstanding shares.
The most significant purchases of SABS for the quarter ending June 2026 came from ADAGE CAPITAL PARTNERS GP, L.L.C. (3.0Mn), BlackRock, Inc. (2.76Mn), GEODE CAPITAL MANAGEMENT, LLC (975.15K), Affinity Asset Advisors, LLC (950.0K), Seven Fleet Capital Management LP (636.08K).
The biggest sellers of SAB Biotherapeutics for the quarter ending June 2026 included Vivo Capital, LLC (4.12Mn), Woodline Partners LP (1.67Mn), Commodore Capital LP (1.53Mn), Ameriprise Financial Inc (865.09K), MILLENNIUM MANAGEMENT LLC (283.61K).
SAB Biotherapeutics's 10 largest shareholders as of June 2026 include Caligan Partners LP (7.97Mn), Vivo Capital, LLC (7.3Mn), PERCEPTIVE ADVISORS LLC (6.63Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (6.41Mn), RA CAPITAL MANAGEMENT, L.P. (4.4Mn), BALYASNY ASSET MANAGEMENT L.P. (3.76Mn), BlackRock, Inc. (3.07Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.97Mn), Commodore Capital LP (2.87Mn), MILLENNIUM MANAGEMENT LLC (2.75Mn) per Business Quant data.

Form 13F Holdings

88 Institutional Holders

Report period 30 Jun, 2026

Total shares held 68.50Mn

Of outstanding 85.89%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Caligan Partners LP	0001727492	7,967,207	9.99%	0	0.00%	$31.07Mn
2	Vivo Capital, LLC	0001674712	7,299,909	9.15%	▼4,120,091	-36.08%	$28.47Mn
3	PERCEPTIVE ADVISORS LLC	0001224962	6,627,501	8.31%	▲195,758	+3.04%	$25.85Mn
4	ADAGE CAPITAL PARTNERS GP, L.L.C.	0001165408	6,405,553	8.03%	▲3,000,000	+88.09%	$24.98Mn
5	RA CAPITAL MANAGEMENT, L.P.	0001346824	4,401,500	5.52%	0	0.00%	$17.17Mn
6	BALYASNY ASSET MANAGEMENT L.P.	0001218710	3,760,439	4.72%	0	0.00%	$14.67Mn
7	BlackRock, Inc.	0002012383	3,066,016	3.84%	▲2,764,690	+917.51%	$11.96Mn
8	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	2,972,929	3.73%	▲479,192	+19.22%	$11.59Mn
9	Commodore Capital LP	0001831942	2,870,000	3.60%	▼1,531,500	-34.79%	$11.19Mn
10	MILLENNIUM MANAGEMENT LLC	0001273087	2,749,087	3.45%	▼283,610	-9.35%	$10.72Mn
11	Spruce Street Capital LP	0002050194	2,198,502	2.76%	0	0.00%	$8.57Mn
12	Sessa Capital IM, L.P.	0001595849	2,198,457	2.76%	0	0.00%	$8.57Mn
13	Affinity Asset Advisors, LLC	0001773195	1,525,000	1.91%	▲950,000	+165.22%	$5.95Mn
14	BOOTHBAY FUND MANAGEMENT, LLC	0001549230	1,481,660	1.86%	0	0.00%	$5.78Mn
15	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,277,185	1.60%	▲975,149	+322.86%	$4.98Mn
16	Woodline Partners LP	0001784547	1,180,355	1.48%	▼1,671,436	-58.61%	$4.60Mn
17	Ensign Peak Advisors, Inc	0001454984	1,172,641	1.47%	▼202,969	-14.75%	$4.57Mn
18	Propel Bio Management, LLC	0001969764	1,076,578	1.35%	▲63,788	+6.30%	$4.20Mn
19	Soleus Capital Management, L.P.	0001802630	900,000	1.13%	▼150,000	-14.29%	$3.51Mn
20	Seven Fleet Capital Management LP	0002092021	736,077	0.92%	▲636,077	+636.08%	$2.87Mn

Showing 1 to 20 of 88 holders